Persistent URL of this record https://hdl.handle.net/1887/77621
Documents
-
- Download
- qt98d1m6ss
- Not Applicable (or Unknown)
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
- All authors
- Heijde, D. van der; Baraliakos, X.; Gensler, L.S.; Maksymowych, W.P.; Tseluyko, V.; Nadashkevich, O.; Abi-Saab, W.; Tasset, C.; Meuleners, L.; Besuyen, R.; Hendrikx, T.; Mozaffarian, N.; Liu, K.; Greer, J.M.; Deodhar, A.; Landewe, R.
- Date
- 2018-12-01
- Journal
- Lancet
- Volume
- 392
- Issue
- 10162
- Pages
- 2378 - 2387